Top Injectable Manufacturer in Iran – Reliable Pharmaceutical Solutions
- Maulik Sudani
- Jul 11
- 8 min read
Last Updated: July 11, 2026
TL;DR: Iran — a nation of more than 92 million people with one of the most developed domestic pharmaceutical industries in the Middle East — produces most of its medicines locally, yet still relies on imports for a significant share of specialised sterile injectables, oncology and biotech products, and a large proportion of its active pharmaceutical ingredients. Every imported sterile injectable must hold an Iran Registration Code (IRC) issued by the Iran Food and Drug Administration (IFDA) under the Ministry of Health and Medical Education, be brought in through a licensed importer, be supported by a Certificate of Pharmaceutical Product, be manufactured to WHO-GMP standards, and carry Persian-language labelling and leaflets. Farbe Firma Pvt Ltd is a WHO-GMP certified injectable manufacturer in Iran's supply chain and a CDMO in Gujarat, India, producing more than 100 sterile injectables under ISO Class 5 aseptic conditions and exporting to 30+ countries, with complete CTD/eCTD dossiers, drug master files and ICH stability data ready to support IFDA registration, API supply and contract-manufacturing and technology-transfer partnerships for Iranian companies.
Key Takeaways
Market and regulatory pathway: every imported sterile injectable must hold an Iran Registration Code (IRC) from the Iran Food and Drug Administration (IFDA), be brought in through a licensed importer, be backed by a Certificate of Pharmaceutical Product and WHO-GMP evidence, and carry Persian labelling; Farbe Firma builds every dossier and supply arrangement around IFDA requirements and Iran's TTAC track-and-trace serialisation expectations.
Certified manufacturing: WHO-GMP certified plant with an ISO Class 5 aseptic core, validated water-for-injection loops, terminal moist-heat sterilisation where the formulation qualifies and full aseptic processing where it does not, HPLC and LAL testing and 100% visual inspection on every batch.
CTD dossier and API support: full CTD/eCTD modules, ICH Q1A long-term and accelerated stability and ICH Q1B photostability data, sterilisation and container-closure packages, drug master files and Certificate-of-Pharmaceutical-Product documentation for IFDA IRC registration — plus active pharmaceutical ingredient supply for Iran's large domestic manufacturing base.
End-to-end CDMO and technology transfer: contract and third-party manufacturing and technology-transfer support across 100+ sterile injectables — ampoules, vials, lyophilised products and pre-filled presentations — with Persian artwork and leaflets, tamper-evident tender-ready packaging and import/export coordination to Bandar Abbas, Tehran and beyond.
Introduction: Why an Injectable Manufacturer in Iran Must Meet Global Standards
Iran is one of the largest pharmaceutical markets in the Middle East, serving more than 92 million people through a broad public and private health system, and it is unusual in the region for the strength of its domestic pharmaceutical industry, which supplies the great majority of the medicines the country consumes by volume. Across its hospitals, its social-insurance-funded outpatient care and its specialist oncology and transplant centres the demand for sterile injectables is immense — antibiotics, anaesthetics, emergency and critical-care drugs, oncology therapies, analgesics and maternal-health products. Every one of them has to reach hospitals and clinics sterile, correctly labelled and exactly to specification, batch after batch, whether it is destined for a teaching hospital in Tehran, Mashhad or Isfahan or a regional hospital in the provinces.
Even with that strong domestic base, Iran still imports a significant share of its specialised sterile injectables, oncology and biotechnology products and the raw materials behind them — it relies on imports for a large proportion of its active pharmaceutical ingredients — which makes reliable overseas manufacturing and API partners strategically important. Any imported product must clear a demanding regulatory pathway: every medicine must hold an Iran Registration Code (IRC) issued by the Iran Food and Drug Administration (IFDA, Sazman-e Ghaza va Daru) under the Ministry of Health and Medical Education; imports must move through a licensed importer; the manufacturing site must satisfy WHO-GMP and be documented with a Certificate of Pharmaceutical Product; the labelling and patient leaflet must be translated into Persian; and products are expected to carry the serialisation required by Iran's TTAC track-and-trace system. An injectable manufacturer that wants to serve Iran well has to treat these requirements not as afterthoughts but as core design inputs — which is exactly how Farbe Firma approaches the market.
What Sets a World-Class Injectable Manufacturer in Iran Apart
The first differentiator is genuine sterile-manufacturing capability. A world-class injectable manufacturer serving Iran runs a WHO-GMP certified plant with an ISO Class 5 (Grade A) aseptic core, validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, and both terminal moist-heat sterilisation and full aseptic processing so that each product is made by the route its formulation and container actually justify. It backs that with a proper analytical laboratory — stability-indicating HPLC assay and related-substance control, bacterial endotoxin testing by LAL, sterility testing, and particulate and container-closure-integrity checks — and a broad portfolio of more than 100 injectables in ampoule, vial, lyophilised and pre-filled formats, so an Iranian importer, hospital or manufacturing partner can consolidate many finished-product and API needs with a single qualified source.
The second differentiator is registration, API and partnership support built specifically around Iran. Because the IFDA reviews dossiers on ICH-CTD lines, a strong partner prepares complete, review-ready CTD/eCTD modules with ICH Q1A stability and ICH Q1B photostability data, drug master files, sterilisation and container-closure reports, method-validation packages and a Certificate of Pharmaceutical Product — the documentation a licensed importer's regulatory team needs to obtain an IRC without gaps or delays. Because Iran's own manufacturers are so capable, the most valuable partner also offers active pharmaceutical ingredients, bulk and semi-finished supply, and contract-manufacturing and technology-transfer arrangements that let Iranian companies fill, finish or formulate locally. It supplies Persian artwork and package inserts and supports the TTAC serialisation the market expects. This combination of manufacturing depth, API supply and Iran-specific dossier and partnership support is what separates a true injectable manufacturer in Iran's supply chain from a mere exporter.
Quality Systems Behind Every Batch We Ship to Iran
Every Farbe Firma injectable batch destined for Iran is released only after a full stack of quality checks: stability-indicating HPLC assay against pharmacopoeial reference standards, control of related substances and degradation products, solution pH and clarity, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the ampoule, vial or pre-filled format. Certificates of analysis are issued with full traceability back to each API lot, the primary-packaging lot and the qualified person responsible for release, so a licensed importer's regulatory-affairs team and IFDA reviewers can see a complete, auditable chain from raw material to finished unit.
Around those release tests sits a deeper quality architecture: validated water-for-injection systems, qualified and monitored cleanrooms, validated sterilisation and depyrogenation equipment, validated filling lines with 100% inspection, and an electronic batch-record system tied into formal deviation, change-control and CAPA workflows. Stability is tracked under both long-term (30 °C / 75 % RH, the ICH Zone IVb condition appropriate to the hot southern provinces around Bandar Abbas) and accelerated (40 °C / 75 % RH) conditions, with a photostability challenge where relevant, so registered shelf lives are supported by data generated under conditions that reflect how the product will actually be stored and transported — from the port of Bandar Abbas and the gateway of Tehran to hospitals across the plateau and the provinces.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Iran for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables at its WHO-GMP certified facility in Gujarat, India, spanning antibiotic, anaesthesia, emergency and critical-care, gastrointestinal, anti-emetic, analgesic, vitamin and specialty ranges — the categories Iranian hospitals, importers and manufacturers need most, including the specialty and critical-care injectables and the active pharmaceutical ingredients that complement Iran's strong domestic production. For Iranian partners we supply finished sterile injectables ready for IFDA registration, along with API and bulk supply, with market-specific strengths, fill volumes, Persian artwork and tamper-evident packs available under contract-manufacturing agreements, and every batch released to WHO-GMP standards with its CTD data package and Certificate of Pharmaceutical Product ready for the importer's IRC filing.
Our CDMO services scale cleanly from a single importer's launch portfolio to long-term API supply and technology-transfer partnerships with Iranian manufacturers. We prepare complete CTD/eCTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substance method-validation data, sterilisation and container-closure reports, a Certificate of Pharmaceutical Product, and translated Persian inserts and artwork. Our regulatory, manufacturing and logistics teams coordinate registration timelines, line slots and shipping to Bandar Abbas, Tehran and other entry points as a single, managed programme rather than a series of disconnected transactions, and we structure documentation so that products carry the TTAC serialisation the market requires.
Buyers stay with Farbe Firma because of audit-readiness and communication. Iranian importers, manufacturing partners and their auditors are welcomed onto the plant floor and into the compounding and filling suites; our quality unit answers technical and regulatory queries with primary data rather than slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, sterile-process design, stability strategy for a Zone IVb climate, CTD dossier structure, IFDA IRC steps, technology transfer and serialisation in real detail. For an importer, hospital or manufacturer that has to answer to the IFDA and to its own patients, that transparency is exactly what makes a distant manufacturer feel like a dependable local partner.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer that can supply Iran?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures more than 100 sterile injectables at its Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, terminal and aseptic sterilisation routes, HPLC and LAL testing, 100% inspection and continuous environmental monitoring. We already export to 30+ countries and prepare every batch and dossier to support import and IFDA registration in Iran through a licensed importer, alongside API supply and contract-manufacturing partnerships.
How does Farbe Firma support IFDA registration and the Iran Registration Code (IRC)?
We provide complete CTD/eCTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability data, sterilisation and container-closure reports, method-validation packages and a Certificate of Pharmaceutical Product — the technical documentation a licensed importer's regulatory team needs to obtain an Iran Registration Code (IRC) from the Iran Food and Drug Administration (IFDA). We also supply Persian artwork and package inserts and support the TTAC serialisation the market expects.
Can Farbe Firma supply active pharmaceutical ingredients and technology transfer to Iranian manufacturers?
Yes. Because Iran has a strong domestic pharmaceutical industry, much of our value lies in supplying active pharmaceutical ingredients and bulk material, and in contract-manufacturing and technology-transfer partnerships that let Iranian companies formulate, fill or finish locally. We provide drug master files, method-validation packages and stability data to support local registration and manufacturing under IFDA rules.
Which injectables can Farbe Firma supply to Iranian hospitals and importers?
Our portfolio of 100+ sterile injectables covers antibiotics, anaesthetics, emergency and critical-care drugs, analgesics, anti-emetics, gastrointestinal agents, vitamins and specialty products in ampoule, vial, lyophilised and pre-filled formats — with an emphasis on the specialty and critical-care injectables and APIs that complement Iran's domestic production. Market-specific strengths and pack sizes are available under contract.
What is the minimum order quantity for injectable contract manufacturing for Iran?
MOQs vary by product, format, sterilisation route, label complexity and dossier requirements. We accommodate single-importer launch quantities, bulk API supply and full technology-transfer partnerships for the Iranian market. Contact director@farbefirma.org for a specific quotation and a registration and supply plan for your product list.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments